type
interferon
ifni
first
cytokin
discov
year
ago
base
potent
antivir
effect
ifni
play
crucial
nonredund
role
vertebr
antivir
defens
ifni
also
mediat
protect
effect
physiopatholog
context
includ
cancer
multipl
sclerosi
ms
contrari
ifni
respons
deleteri
number
circumst
includ
bacteri
fungal
infect
mani
autoimmun
diseas
paradox
certain
chronic
viral
infect
recent
integr
pictur
emerg
cellular
molecular
mechan
regul
product
ifni
underli
function
much
knowledg
gain
recent
anoth
class
potent
innat
antivir
interferon
lambda
type
iii
ifn
ifniii
review
knowledg
ifniiii
ifn
discuss
could
har
develop
innov
therapeut
strategi
aim
surgic
tune
ifn
activ
toward
protect
respons
manner
adapt
diseas
focu
best
character
ifn
alreadi
use
therapeut
recent
review
cover
inform
ifni
subset
includ
produc
mucos
site
promot
local
antivir
defens
dendrit
cell
dc
rare
heterogen
mononuclear
phagocyt
function
character
uniqu
efficaci
antigenspecif
activ
lymphocyt
dc
sentinel
cell
immun
system
abl
sens
integr
varieti
danger
input
signal
deliveri
output
signal
instruct
activ
function
polar
effector
immun
cell
mammal
five
major
dc
subset
exist
differ
express
innat
immun
recognit
receptor
function
special
monocytederiv
dc
modc
langerhan
cell
dc
dc
plasmacytoid
dc
pdc
recurr
theme
review
intric
relationship
ifn
dc
sinc
cell
major
sourc
andor
target
cytokin
variou
condit
first
section
synthes
current
knowledg
ifn
product
protect
antivir
function
downstream
signal
pathway
respons
ifni
product
viral
infect
list
role
differ
cell
type
function
discuss
two
main
mechan
ifni
promot
antivir
defens
review
succinctli
direct
antivir
effect
greater
detail
immunoregulatori
function
second
section
focu
detriment
function
ifni
select
diseas
discuss
illustr
differ
sometim
opposit
process
underli
deleteri
ifni
respons
depend
physiopatholog
context
ifni
induct
unbridl
inflammatori
respons
caus
lethal
tissu
damag
discuss
major
patholog
mechan
bacteri
encount
secondari
influenza
infect
autoimmun
diseas
inappropri
function
polar
immun
respons
ifni
discuss
one
potenti
caus
enhanc
suscept
bacteri
fungal
infect
complex
disput
role
ifni
chronic
viral
infect
review
emphasi
physiopatholog
infect
human
immunodefici
viru
type
human
hepat
c
viru
hcv
outlook
develop
novel
immunotherapeut
strategi
combin
antivir
drug
third
section
recapitul
balanc
benefici
versu
deleteri
ifni
respons
modul
sever
key
paramet
includ
sourc
time
ifni
product
ii
cell
type
affect
ifni
iii
signal
pathway
activ
ifni
last
section
specul
integr
knowledg
discuss
combin
advanc
biochem
manipul
activ
cytokin
allow
design
innov
immunotherapeut
treatment
base
induct
blockad
specif
ifni
respons
target
cell
type
activitybytarget
concept
base
design
novel
immunoifn
consist
coval
associ
mutat
ifni
decreas
affin
receptor
antibodi
high
avid
molecul
specif
express
target
cell
type
design
ensur
lack
activ
immunoifn
cell
type
target
contrari
previou
strategi
use
ifn
close
maxim
potenc
still
abl
mediat
strong
offtarget
effect
despit
coupl
celltyp
specif
antibodi
andor
local
deliveri
infect
cell
sens
abnorm
chang
physic
biochem
properti
plasma
membran
upon
viru
entri
trigger
product
ifni
event
depend
signal
endoplasm
reticulum
er
resid
transmembran
protein
stimul
interferon
gene
sting
upon
viru
entri
sting
transloc
cytosol
activ
phosphatidylinositol
calciumdepend
pathway
initi
signal
cascad
lead
induct
ifni
isg
figur
locat
cytosol
bind
viral
nucleotid
sequenc
induc
ifni
product
infect
cell
classifi
cytosol
rna
dna
sensor
specif
particular
nucleotid
sequenc
tertiari
structur
signal
pathway
physiolog
signific
recent
review
cytosol
rna
sensor
encompass
dexdh
helicas
among
retinoicacidinduc
gene
rig
ilik
receptor
rlr
studi
name
rigi
melanoma
differenti
associ
gene
rigi
recogn
rna
uncap
moieti
doublestrand
rna
dsrna
structur
present
viral
cytosol
eukaryot
rna
molecul
might
specif
recogn
long
dsrna
fragment
rigi
contain
dexdh
boxcontain
rna
helicas
domain
caspas
recruit
domain
bind
mitochondri
antivir
signal
protein
mav
rnarlrst
molecular
complex
initi
signal
cascad
lead
induct
ifn
figur
dexdh
helicas
promot
ifni
product
dc
although
physiolog
role
vivo
immun
defens
viral
infect
remain
establish
cytosol
dna
sensor
abl
induc
ifni
mostli
ifniii
encompass
molecul
belong
differ
protein
famili
includ
dexdh
helicas
inflammasom
compon
protein
zdna
bind
protein
cyclic
gmpamp
cgamp
synthas
cga
cytosol
dna
sensor
activ
sting
lead
induct
ifniii
mani
cell
type
express
abl
produc
ifni
upon
trigger
molecul
includ
macrophag
dc
fibroblast
follow
infect
upon
dna
bind
cga
catalyz
product
cgamp
cga
critic
detect
lentivirus
includ
contribut
sens
protect
rna
virus
includ
vivo
mice
cgamp
also
act
secret
second
messeng
signal
alert
uninfect
cell
directli
induc
express
intrins
immun
antivir
defens
signal
cascad
transcript
factor
master
induc
cellintrins
immun
abl
control
replic
dna
rna
virus
least
part
independ
ifn
infect
cell
becom
factori
product
viral
particl
hijack
translat
apparatu
host
cell
massiv
product
viral
structur
protein
lead
overload
capac
er
correct
fold
newli
synthes
protein
er
overload
induc
homeostat
respons
cell
unfold
protein
respons
upr
upr
aim
restor
normal
er
function
inhibit
translat
upr
activ
infect
cell
contribut
prevent
viral
replic
includ
inhibit
product
viral
protein
promot
ifni
product
induct
cell
suicid
plasmacytoid
dc
uniqu
produc
larg
amount
ifn
respons
vitro
stimul
mani
virus
without
infect
ifni
mrna
repres
mrna
pdc
peak
activ
vitro
upon
exposur
influenza
viru
herp
viru
type
cytomegalovirus
vesicular
stomat
viru
individu
pdc
produc
time
ifn
total
pbmc
monocyt
modc
cdc
neutrophil
fibroblast
howev
vitro
high
molar
infect
cdc
certain
virus
unabl
inhibit
ifni
product
target
cell
also
induc
massiv
secret
pdc
produc
high
level
subtyp
ifn
contrari
mani
cell
type
includ
infect
cell
often
preferenti
produc
vivo
pdc
deplet
system
viral
infect
lead
decreas
ifni
product
total
number
pdc
produc
ifni
one
mous
much
lower
total
number
infect
cell
show
vivo
also
individu
activ
pdc
produc
much
ifniiii
cell
type
includ
virusinfect
cell
profession
ifnproduc
function
pdc
larg
result
high
constitut
select
express
figur
molecul
preassoci
readytosign
complex
locat
special
endosom
specif
pdc
pdc
must
also
equip
effici
sens
uptak
virion
virusinfect
cell
correspond
cell
surfac
remain
identifi
dc
potent
antigenspecif
activ
cell
particular
crosspresent
exogen
antigen
captur
cell
process
associ
class
major
complex
histocompat
mhci
molecul
mice
dc
crucial
initi
protect
adapt
immun
respons
tumor
varieti
virus
mous
human
dc
constitut
select
express
high
level
figur
produc
larg
amount
ifniii
upon
stimul
synthet
mimet
dsrna
polyinosin
polycytidyl
acid
polyi
c
human
dc
uniqu
respond
stimul
hcv
produc
larg
amount
ifniii
manner
irrespect
infect
addit
induct
posit
feedback
mechan
exist
amplifi
product
ifn
rapidli
initi
viral
infect
illustr
follow
select
exampl
ifn
induc
express
mani
cytosol
rnadna
sensor
broaden
spectrum
host
cell
type
abl
detect
endogen
viral
replic
ifn
induct
induct
oasl
ifn
human
cell
enforc
rigi
signal
counteract
viral
immun
evas
gene
interf
sens
pathway
ifninduc
ribonucleas
l
rnasel
gener
viral
cellular
rna
degrad
product
engag
rlr
amplif
ifn
product
ifninduc
protein
kinas
r
pkr
stabil
ifni
mrna
prevent
unbridl
respons
deleteri
host
ifn
activ
must
tightli
control
includ
viral
infect
sever
neg
feedback
loop
exist
termin
ifn
product
antivir
defens
activ
isg
ubiquitin
specif
peptidas
bind
prevent
recruit
signal
transduc
activ
transcript
ifn
induc
express
tam
receptor
tyrosin
kinas
dc
monocyt
macrophag
tam
receptor
associ
signal
part
activ
suppressor
cytokin
soc
inhibit
tlr
rlr
signal
therebi
termin
ifn
product
tam
receptor
ligand
pro
bind
phosphatidylserin
die
cell
produc
activ
dc
monocytesmacrophag
thu
ifn
induct
tam
inhibitori
receptor
uninfect
phagocyt
immun
cell
could
limit
propens
produc
cytokin
upon
engulf
die
viral
infect
cell
ifn
induc
tetherin
cell
type
pdc
express
receptor
tetherin
leukocyt
immunoglobulinlik
receptor
subfamili
tm
domain
member
trigger
pdc
inhibit
product
ifni
henc
engag
tetherin
pdc
monitor
efficaci
induc
antivir
gene
express
program
neighbor
cell
ifn
time
termin
ifn
product
posit
neg
feedback
loop
integr
time
space
promot
optim
kinet
intens
ifn
product
order
effici
control
viral
infect
without
caus
sever
immunopatholog
complet
understood
posit
feedback
loop
may
occur
rapidli
initi
viral
infect
allow
rapid
secret
high
level
cytokin
fast
strong
induct
antivir
cellintrins
immun
neg
feedback
loop
occur
like
later
termin
respons
thu
avoid
chronic
cytokin
product
ensu
deleteri
effect
pdc
constitut
major
sourc
ifn
product
upon
local
infect
sever
virus
lung
femal
reproduct
tract
pdc
dispens
resist
infect
pulmonari
infect
newcastl
diseas
viru
ndv
ifni
produc
local
lung
mainli
infect
alveolar
macrophag
lung
pdc
express
cytokin
select
deplet
lung
alveolar
macrophag
lead
system
dissemin
ndv
strong
activ
pdc
ifni
product
specif
spleen
even
case
system
viral
infect
caus
intraven
inject
ndv
intraperiton
inject
mous
cytomegaloviru
mcmv
pdc
ifn
product
confin
spleen
detect
organ
even
high
viral
replic
henc
splenic
pdc
especi
prone
high
level
ifn
product
upon
system
acut
viral
infect
pdc
locat
nonlymphoid
organ
particular
mucos
barrier
tissu
appear
inhibit
ifn
product
thu
ifn
product
infect
cell
serv
first
line
defens
block
viru
replic
portal
entri
bodi
ifn
product
uninfect
pdc
might
constitut
failsaf
mechan
mainli
activ
spleen
viral
infect
get
system
condit
promot
health
diseas
benefit
host
produc
high
circul
level
ifn
order
induc
widespread
cellintrins
antivir
defens
might
prevail
deleteri
effect
could
caus
certain
cell
type
tissu
inde
pdc
requir
protect
mice
system
local
infect
observ
consist
crucial
role
pdc
protect
mice
system
infect
mous
hepat
viru
mhv
fast
replic
coronaviru
conflict
result
obtain
role
pdc
intranas
influenza
infect
possibl
explan
pdc
ifn
product
contribut
resist
highli
pathogen
influenza
strain
might
system
spread
lung
earli
infect
even
low
level
anoth
intrigu
observ
ifn
critic
host
resist
mcmv
pdc
major
sourc
ifn
infect
model
dispens
viru
control
studi
ongo
understand
appar
paradox
patient
bear
genet
mutat
disrupt
endosom
tlr
signal
appear
suffer
lifethreaten
viral
infect
contrari
patient
impair
ifnar
signal
notabl
except
specif
suscept
sever
herp
viru
enceph
individu
defici
signal
howev
contrari
extracellular
tlr
endosom
tlr
evolv
strong
purifi
select
human
be
henc
pdc
endosom
tlr
might
requir
protect
speci
viral
infect
past
appear
case
anymor
perhap
due
improv
social
hygien
health
care
modern
societi
attest
import
ifn
antivir
defens
vertebr
mani
mammalian
virus
encod
immun
evas
gene
specif
inhibit
product
ifn
infect
cell
pdc
dc
might
essenti
ifndepend
host
protect
virus
spare
intracellular
function
viral
immun
evas
gene
best
knowledg
mcmv
encod
immun
evas
gene
inhibit
ifn
product
howev
mcmv
manipul
ifni
respons
specif
inhibit
function
infect
cell
thu
pdc
might
dispens
resist
system
mcmv
infect
due
suffici
level
ifn
product
infect
cell
local
infect
tissu
hepatocyt
respons
ifniii
appear
play
critic
role
human
resist
hcv
infect
hepatocyt
hcv
induc
express
cellular
microrna
bind
ifniii
mrna
lead
degrad
uninfect
dc
produc
high
level
ifniii
vitro
upon
hcv
stimul
henc
acut
hcv
infect
vivo
dc
may
strong
earli
sourc
ifniii
subject
viru
immun
evas
strategi
therefor
contribut
protect
natur
resist
individu
secondari
lymphoid
organ
subset
macrophag
critic
clearanc
virus
lymph
macrophag
locat
viral
entri
rout
near
subcapsular
sinus
affer
lymph
drain
nonlymphoid
tissu
flow
contrari
subset
macrophag
subcapsular
sinu
macrophag
highli
suscept
viral
infect
constitut
express
low
level
effector
molecul
cellintrins
antivir
immun
respons
ifn
inhibit
high
constitut
express
subcapsular
sinu
macrophag
rapidli
becom
infect
virus
incom
lymph
produc
larg
amount
ifn
altruist
suicid
prevent
viru
dissemin
adjac
cell
type
promot
induct
innat
adapt
antivir
immun
upon
instruct
ifn
cell
express
wide
varieti
viral
restrict
factor
whose
combin
action
block
pathogen
invas
interf
differ
stage
viral
life
cycl
figur
extens
review
recent
describ
succinctli
viru
fusion
host
cell
membran
block
inhibit
sterol
biosynthesi
virus
enter
cell
escap
endosomeslysosom
block
interferon
induc
transmembran
ifitm
protein
viru
uncoat
block
tripartit
motif
trim
protein
bind
capsid
thu
promot
degrad
myxoma
resist
gtpase
effici
trap
viral
structur
protein
earli
stage
follow
viru
entri
cell
inhibit
number
virus
includ
influenza
viru
sequestr
nucleocapsid
associ
host
cyclophilin
capsid
protein
virion
assembl
block
transcript
translat
posttransl
level
adenosin
deaminas
act
rna
apolipoprotein
b
mrna
edit
enzym
catalyt
polypeptidelik
apobec
deaminas
induc
viral
rna
destabil
hypermut
steril
alpha
motif
histidineaspart
domain
hd
contain
protein
block
revers
transcript
hydrolyz
dntp
apobec
function
mainli
studi
infect
retrovirus
synthas
oa
protein
ifninduc
protein
tetratricopeptid
repeat
ifit
pkr
inhibit
viral
host
protein
translat
use
complementari
mechan
major
posttransl
modif
induc
ifn
bind
ubiquitinlik
modifi
sever
viral
host
protein
process
call
isgyl
known
isgyl
protein
target
degrad
except
contrari
stabil
like
final
egress
bud
virion
mani
envelop
virus
inhibit
tetherin
viperin
mani
antivir
isg
function
character
recent
larg
thank
largescal
screen
approach
display
variabl
degre
viral
specif
might
invers
relat
extent
side
effect
host
cell
figur
antivir
effector
act
broad
spectrum
virus
often
target
key
metabol
pathway
also
crucial
host
cell
function
case
control
cholesterol
metabol
protein
translat
pkr
oa
ifit
antivir
restrict
factor
may
specif
target
one
molecul
restrict
set
virus
appar
side
effect
host
cell
antivir
isg
target
specif
function
critic
restrict
array
virus
might
similarli
exert
side
effect
subset
host
cell
type
exampl
inhibit
retroviru
replic
dntp
deplet
might
specif
affect
prolifer
host
cell
henc
infect
host
must
balanc
intens
breadth
locat
isg
induct
circumv
viral
replic
prevent
lifethreaten
damag
vital
cell
type
tissu
one
mechan
contribut
balanc
translat
control
express
isg
especi
proapoptot
antiprolif
function
mani
antivir
isg
transcript
activ
ifnstimul
cell
translat
specif
block
uninfect
cell
cellular
microrna
inhibit
reliev
upon
cell
infect
neg
regul
function
rnainduc
silenc
complex
henc
ifn
stimul
uninfect
cell
prepar
rapid
strong
induct
cellintrins
antivir
defens
upon
viral
infect
avoid
unnecessari
exposur
toxic
effect
certain
isg
knowledg
function
dynam
regul
isg
essenti
develop
novel
therapeut
strategi
viral
infect
aim
modul
ifn
respons
promot
protect
antivir
cellintrins
function
deleteri
toxic
effect
better
understand
immunoregulatori
effect
ifn
also
help
type
interferon
modul
function
broad
spectrum
immun
cell
figur
review
knowledg
focus
function
dc
nk
cell
cell
b
cell
sinc
involv
control
viral
infect
discuss
hypothesi
dc
play
central
role
ifni
orchestr
innat
adapt
immun
induct
optim
antivir
defens
figur
viral
infect
cancer
immunosurveil
ifni
constitut
one
import
input
signal
act
dc
promot
deliveri
appropri
output
signal
cell
b
cell
nk
cell
protect
immun
figur
dc
deliv
three
type
signal
activ
function
polar
cell
signal
trigger
cell
receptor
viral
peptidemhc
complex
signal
trigger
activ
cell
costimul
receptor
costimul
molecul
express
dc
signal
correspond
cytokin
promot
cell
prolifer
acquisit
specif
effector
function
steadi
state
condit
dc
immatur
state
character
low
level
express
mhcii
signal
costimul
molecul
signal
lack
product
cellactiv
cytokin
signal
upon
activ
includ
earli
viral
infect
vivo
dc
upregul
express
signal
activ
signal
secret
cellactiv
cytokin
process
call
dc
matur
gene
express
profil
dc
stimul
microbi
stimuli
identifi
core
set
gene
upregul
matur
dc
irrespect
stimulu
receiv
irrespect
subset
belong
conserv
across
evolut
gene
induc
dc
matur
part
cellintrins
ifni
signal
consist
cellintrins
ifnar
signal
dc
requir
mani
circumst
induct
protect
immun
includ
effici
cell
respons
viral
infect
tumor
develop
respons
upon
polyi
c
inject
independ
effect
well
follicular
helper
cell
humor
respons
mechanist
ifni
promot
dc
immunogen
effici
cell
activ
varieti
effect
figur
drive
dc
upregul
signal
vivo
viral
infect
boost
capac
crosspres
antigen
increas
deliveri
signal
cell
shape
deliveri
activ
signal
particular
induc
promot
inhibit
depend
experiment
condit
final
necessari
induc
metabol
shift
mitochondri
oxid
phosphoryl
aerob
glycolysi
fuel
increas
need
energi
expans
intracellular
organel
requir
product
proper
intracellular
rout
signal
protein
select
inactiv
ifnar
cdc
compromis
mous
resist
mcmv
mhv
infect
contrast
ifnar
express
requir
nk
cell
protect
mcmv
pdc
cell
b
cell
earli
control
mhv
replic
although
cellintrins
ifni
signal
nk
cell
promot
activ
figur
ifniinduc
transpresent
dc
play
promin
role
function
mani
condit
includ
vivo
mcmv
infect
figur
cellintrins
ifni
signal
cell
cell
b
cell
also
contribut
effici
activ
function
polar
figur
depend
experiment
set
cellintrins
ifni
respons
crucial
mount
effici
cytotox
cell
respons
lcmv
less
critic
vaccinia
viru
vesicular
stomat
viru
mechanist
cellintrins
ifni
signal
cell
promot
surviv
antigeninduc
prolifer
cellintrins
signal
dc
cell
may
act
synergist
manner
inde
condit
inactiv
ifni
respons
requir
occur
simultan
two
cell
type
dramat
affect
cell
expans
upon
vaccin
modifi
ankara
vaccinia
viru
summari
ifni
gener
play
crucial
benefici
role
immun
defens
viral
infect
induct
cellintrins
antivir
defens
orchestr
innat
adapt
immun
howev
respons
properli
regul
contribut
diseas
discuss
frequent
side
effect
ifni
treatment
cancer
chronic
viral
infect
induct
autoimmun
reaction
consist
isg
express
hallmark
mani
spontan
system
tissuespecif
autoimmun
diseas
includ
system
lupu
erythematos
sle
sjogren
syndrom
psoriasi
skin
disord
dysregul
ifni
respons
observ
patient
autoimmun
diseas
like
result
genet
environment
factor
genomewid
associ
studi
show
polymorph
gene
involv
ifni
respons
strongli
correl
increas
suscept
mani
autoimmun
diseas
divers
environment
factor
also
contribut
onset
autoimmun
diseas
microbi
infect
often
preced
first
clinic
manifest
autoimmun
diseas
whether
infect
andor
alter
commens
microbiota
affect
barrier
tissu
caus
rather
consequ
autoimmun
still
matter
debat
infect
dysbiosisinduc
tissu
damag
unbridl
ifni
respons
contribut
initi
autoimmun
reaction
gender
anoth
promin
factor
affect
suscept
autoimmun
diseas
women
prone
autoimmun
may
result
endocrin
regul
ifni
respons
pdc
ifni
product
enhanc
human
mous
femal
due
least
part
cellintrins
enhanc
respons
femal
hormon
estradiol
autoimmun
diseas
differ
mechan
could
oper
initi
dysregul
immun
respons
lead
viciou
circl
reciproc
activ
innat
ifni
respons
adapt
selfreact
lymphocyt
respons
figur
adapt
immun
cell
educ
spare
self
occur
neg
select
potenti
autoimmun
b
cell
develop
bone
marrow
thymu
respect
process
call
central
toler
selfreact
b
cell
escap
prune
either
delet
function
inactiv
egress
secondari
lymphoid
organ
nonlymphoid
tissu
process
call
peripher
toler
individu
polymorph
gene
involv
promot
central
peripher
toler
lead
higher
number
divers
andor
respons
selfreact
lymphocyt
peripheri
particular
b
cell
secret
antidna
antirnp
antibodi
mammalian
dna
rna
poor
induc
pdc
ifni
induct
normal
condit
howev
preexist
antidna
antirnp
autoantibodi
break
innat
toler
pdc
inde
antibodi
bind
self
nucleic
acid
protect
degrad
compact
nanoparticl
effect
induct
ifni
pdc
figur
dnacontain
immun
complex
ic
frequent
found
serum
sle
patient
sleic
activ
pdc
ifni
product
turn
pdc
ifni
activ
cdc
monocyt
b
cell
lead
viciou
circl
reciproc
activ
dc
selfreact
lymphocyt
exacerb
autoimmun
respons
figur
certain
infect
dysbiosi
commens
microbiota
affect
barrier
tissu
could
promot
chronic
product
host
amphiphat
peptid
abl
combin
eukaryot
dna
rna
like
releas
die
cell
thu
form
pdcactiv
nanoparticl
inde
psoriat
skin
high
express
massiv
infiltr
pdc
observ
figur
henc
treat
mani
autoimmun
diseas
novel
therapeut
strategi
could
design
target
dysregul
pdc
ifni
product
b
cell
activ
ifni
one
common
complic
primari
infect
mani
respiratori
virus
particular
influenza
viru
lifethreaten
pneumonia
due
secondari
pulmonari
infect
bacteria
streptococcu
pneumonia
staphylococcu
aureu
haemophilu
influenza
patholog
affect
especi
infant
elderli
immunocompromis
patient
retrospect
studi
indic
secondari
bacteri
pneumonia
highli
recurr
lung
tissu
isol
patient
die
last
centuri
influenza
pandem
independ
antibiot
avail
influenza
viru
induc
high
ifni
respons
human
be
mice
host
secondari
bacteri
infect
lethal
occur
limit
time
window
follow
primari
viral
infect
day
around
peak
ifni
respons
complet
viru
clearanc
mous
model
viralbacteri
coinfect
use
dissect
diseas
mechan
mice
appear
resist
secondari
pulmonari
bacteri
infect
show
ifni
respons
contribut
diseas
similarli
lymphochoriomening
viru
lcmv
infect
wildtyp
mice
suscept
lpsinduc
septic
shock
sever
mechan
may
contribut
detriment
role
ifni
secondari
bacteri
infect
figur
earli
viral
infect
ifni
decreas
host
abil
control
bacteri
replic
dominantli
polar
immun
respons
toward
antivir
function
simultan
inhibit
develop
type
immun
respons
requir
protect
bacteri
infect
ifni
inhibit
product
chemokin
requir
recruit
respiratori
tract
antibacteri
effector
innat
immun
cell
particular
neutrophil
monocytesmacrophag
figur
depend
experiment
model
use
ifni
contrari
induc
recruit
classic
monocyt
infect
tissu
ifni
might
skew
function
polar
resid
infiltr
monocyt
cell
toward
immunosuppress
limit
antibacteri
function
inhibit
product
might
promot
product
nitric
oxygen
intermedi
exact
natur
infiltr
monocyt
cell
clear
could
correspond
activ
classic
monocyt
modc
monocytederiv
macrophag
myeloidderiv
suppressor
cell
mdsc
boundari
put
differ
cell
type
current
illdefin
cell
could
fuel
local
replic
monocytemacrophagetrop
bacteria
immunosuppress
contribut
local
immunopatholog
role
ifni
monocytesmacrophag
complex
requir
investig
determin
protect
versu
deleteri
underli
mechan
depend
context
ifni
either
promot
inhibit
induct
cytokin
myeloid
cell
respons
ifni
also
polar
cell
respons
toward
expens
cytokin
requir
host
defens
pulmonari
bacteria
induc
product
antimicrobi
peptid
tissu
repair
molecul
figur
ifni
may
affect
host
resist
bacteri
infect
also
host
toler
ie
abil
host
toler
given
burden
pathogen
without
undergo
excess
tissu
damag
henc
counter
ifni
deleteri
effect
secondari
bacteri
infect
import
better
delin
respect
contribut
lung
tissu
toler
modul
immunemedi
resist
weaken
anoth
well
document
exampl
deleteri
effect
ifni
due
inappropri
function
polar
immun
respons
enhanc
suscept
fungal
infect
patient
genet
determin
hyperact
ifni
respons
exemplifi
hereditari
diseas
chronic
mucocutan
candidiadi
cmc
figur
patient
cmc
signific
deficit
cell
least
part
consequ
alter
respons
sever
mutat
identifi
patient
autosom
domin
cmc
gainoffunct
mutat
found
hard
wire
cell
respons
cytokin
toward
signal
compromis
abil
produc
upon
stimul
associ
induct
global
ifni
transcriptom
signatur
blood
deleteri
ifni
effect
immun
candida
might
occur
cmc
patient
also
type
individu
upon
secondari
fungal
infect
occur
shortli
primari
viral
infect
likewis
situat
discuss
secondari
bacteri
infect
inde
polyic
induc
ifni
abrog
innat
immun
system
candidiasi
mice
ifnardefici
mice
resist
candida
infect
certain
experiment
set
howev
role
ifni
modul
abil
immunocompet
host
control
fungal
infect
disput
inhibit
respons
ifni
could
protect
least
one
import
human
patholog
ms
figur
ms
repres
strike
except
previous
discuss
detriment
role
ifni
autoimmun
diseas
inde
larg
proport
ms
patient
low
serum
ifni
activ
low
isg
level
ms
patient
present
signific
reduct
ms
relaps
upon
administr
underli
mechan
yet
complet
unravel
howev
experiment
autoimmun
enceph
mous
model
ms
respons
bear
major
contribut
nervou
system
damag
inhibit
induc
upon
ifni
administr
summari
ifni
respons
deleteri
autoimmun
promot
viciou
circl
reciproc
activ
innat
immun
cell
autoreact
b
lymphocyt
ifni
respons
also
deleteri
upon
secondari
bacteri
fungal
infect
lung
kidney
occur
shortli
primari
viral
infect
compromis
recruit
antimicrobi
innat
effector
cell
andor
prevent
proper
function
polar
immun
respons
discuss
ifni
respons
also
compromis
host
immun
defens
certain
virus
promot
chronic
infect
differ
lcmv
strain
armstrong
respect
lead
acut
versu
chronic
infect
mice
hallmark
chronic
lcmv
infect
loss
prolif
potenti
effector
function
antivir
cell
process
call
exhaust
exhaust
cell
character
high
express
inhibitori
receptor
vivo
blockad
inhibitori
receptor
revers
cell
exhaust
allow
resolut
chronic
infect
ifni
isg
induc
earli
infect
strain
lcmv
albeit
lower
level
lead
chronic
infect
earli
ifni
product
critic
limit
viral
replic
model
acut
infect
ifni
respons
rapidli
return
normal
undetect
level
viral
replic
complet
control
contrast
isg
induct
maintain
chronic
infect
includ
express
ligand
apc
immunosuppress
cytokin
consist
prolong
express
ifni
albeit
low
level
vivo
neutral
ifni
antibodi
administr
promot
resolut
chronic
lcmv
infect
allow
restor
function
antivir
cell
respons
least
part
cell
mechan
persist
lcmv
infect
chronic
low
level
ifni
product
polar
cell
respons
toward
follicular
helper
tfh
rather
function
thu
chronic
ifni
respons
promot
enhanc
antivir
b
cell
respons
facilit
cell
exhaust
due
defici
cell
help
therefor
contribut
host
failur
prevent
chronic
infect
strikingli
establish
chronic
infect
lcmv
could
also
prevent
earli
administr
two
shot
high
dose
exogen
ifni
day
postlcmv
inocul
treatment
allow
viral
clearanc
rescu
antivir
cell
exhaust
altogeth
studi
show
time
durat
ifni
product
viral
infect
critic
determin
respons
impact
balanc
viru
host
earli
robust
transient
product
ifni
promot
strong
induct
cellintrins
viral
restrict
mechan
well
adequ
polar
adapt
antivir
immun
respons
combin
effect
lead
viral
clearanc
contrast
product
ifni
low
andor
late
viral
replic
low
ifni
respons
becom
chronic
combin
action
lead
induct
immunosuppress
effect
inadequ
function
polar
cell
result
cell
exhaust
mainten
chronic
infect
chronic
viral
replic
cell
exhaust
also
hallmark
infect
discuss
complex
disput
role
ifni
diseas
infect
relev
anim
model
infect
nonhuman
primat
simian
immunodefici
viru
siv
diseas
progress
acut
phase
infect
associ
high
chronic
express
isg
ifni
product
inconsist
detect
contrast
individu
progress
toward
diseas
despit
persist
high
viral
load
show
much
lower
immun
activ
particular
low
isg
express
acut
phase
infect
henc
chronic
low
level
ifni
associ
diseas
progress
independ
level
viral
replic
therefor
outstand
question
still
open
better
understand
physiopatholog
infect
whether
chronic
ifni
respons
mere
marker
progress
whether
implic
drive
diseas
develop
addit
mechan
similar
uncov
mous
model
chronic
lcmv
infect
infect
effect
ifni
could
promot
viciou
circl
reciproc
activ
chronic
viral
replic
sustain
deleteri
immun
respons
figur
earli
infect
individu
ifni
product
might
weak
late
induc
combin
cellintrins
defens
mechan
immun
respons
effici
enough
prevent
later
establish
chronic
infect
contrari
demonstr
case
mous
model
lcmv
infect
ifni
respons
could
favor
cell
exhaust
either
direct
cellintrins
effect
cell
figur
contribut
depriv
cell
help
figur
sever
effect
ifni
might
compromis
respons
gener
contribut
global
deplet
cell
mechan
includ
function
polar
cell
toward
tfh
rather
respons
product
lead
enhanc
recruit
memori
cell
site
viral
replic
fuel
chronic
viral
replic
new
target
cell
figur
direct
proapoptot
antiprolif
effect
cell
figur
well
trail
induct
pdc
licens
kill
cell
irrespect
infect
figur
altogeth
mechan
entertain
chronic
viral
replic
continu
deplet
cell
lead
dramat
enhanc
suscept
opportunist
infect
figur
characterist
acquir
immunodefici
syndrom
aid
figur
line
evid
report
support
deleteri
role
pdc
activ
infect
women
undergo
faster
diseas
progress
men
similar
viral
load
may
result
part
highest
ifni
product
women
pdc
includ
respons
stimul
pdc
recruit
activ
vagin
mucosa
femal
macaqu
earli
local
siv
inocul
contribut
attract
activ
cell
infect
promot
viru
dissemin
portal
entri
howev
vivo
blockad
pdc
product
administr
oligonucleotid
earli
siv
infect
macaqu
decreas
lymphocyt
activ
suggest
addit
sourc
ifni
like
contribut
immun
dysfunct
observ
infect
target
dysregul
ifni
respons
infect
might
repres
interest
adjuv
therapeut
strategi
highli
activ
antiretrovir
treatment
administr
ifni
nonpathogen
siv
infect
model
sooti
mangabey
suffici
switch
pathogen
model
cell
deplet
ensu
hyperactiv
immun
respons
observ
viral
load
even
significantli
decreas
howev
could
consist
posit
impact
earli
high
dose
ifni
administr
chronic
lcmv
infect
inde
review
process
manuscript
report
earli
primari
siv
infect
pathogen
rhesu
macaqu
model
high
dose
inject
ifni
protect
neutral
endogen
ifni
deleteri
contrast
anim
model
prolong
ifni
administr
acceler
diseas
develop
chronic
stage
infect
mice
human
immun
system
pdc
deplet
strongli
decreas
isg
induct
enhanc
viral
replic
acut
chronic
phase
infect
howev
pdc
deplet
chronic
infect
decreas
infectioninduc
cell
apoptosi
increas
cell
number
lymphoid
organ
result
emphas
dual
role
ifni
pdc
physiopatholog
infect
strong
transient
product
ifni
earli
infect
benefit
host
lower
setpoint
viral
replic
chronic
infect
sustain
product
low
level
ifni
chronic
infect
contribut
immun
dysregul
cell
deplet
studi
necessari
examin
whether
complement
standardofus
antiretrovir
drug
pdc
deplet
ifni
neutral
select
inhibit
cell
respons
ifni
could
yield
addit
benefit
chemotherapi
nonhuman
primat
chronic
siv
infect
ifni
administr
use
mani
year
treat
anoth
human
chronic
viral
diseas
hcv
infect
roughli
half
patient
show
sustain
virolog
respons
svr
treatment
caus
sever
side
effect
mani
individu
new
chemotherapeut
drug
potent
block
hcv
replic
vivo
recent
becom
avail
henc
whether
ifni
administr
still
constitut
viabl
treatment
chronic
hcv
infect
question
discuss
issu
chronic
hcv
infect
main
caus
liver
cirrhosi
hepatocellular
carcinoma
current
vaccin
hcv
common
therapi
chronic
hcv
patient
administr
recombin
pegyl
combin
antivir
drug
ribavirin
howev
ifnar
pleiotrop
express
administr
induc
sever
side
effect
includ
flulik
syndrom
fever
fatigu
myalgia
nervou
depress
figur
moreov
half
treat
patient
harbor
svr
priortotreat
high
hepat
isg
express
neg
predictor
svr
upon
therapi
high
isg
express
untreat
patient
like
result
chronic
low
ifni
product
trigger
persist
hcv
replic
inde
hepatocyt
nonrespond
patient
found
infect
greater
frequenc
exhibit
dampen
antivir
cell
death
respons
cellular
sourc
ifni
product
persist
nonrespond
patient
still
remain
establish
chronic
hcv
infect
cytotox
effector
lymphocyt
may
contribut
develop
hepatocarcinoma
caus
low
level
sustain
hepatocyt
death
renew
contrast
local
product
liver
nk
lymphocyt
could
promot
resist
diseas
noncytolyt
control
viral
replic
discuss
previous
lcmv
low
chronic
product
endogen
ifni
hcv
patient
could
compromis
innat
adapt
antivir
immun
respons
chronic
exposur
ifni
could
dampen
abil
nk
cell
produc
promot
cell
exhaust
could
also
induc
antagonist
form
chemokin
requir
recruit
liver
antivir
nk
cell
effector
may
also
polar
monocyt
toward
immunosuppress
function
therefor
better
understand
ifni
effect
hcv
infect
critic
improv
care
respond
nonrespond
patient
respond
patient
issu
modifi
treatment
favor
benefici
antivir
immunoactiv
effect
side
effect
strongli
affect
patient
qualiti
life
figur
might
achiev
specif
deliveri
ifni
target
cell
type
discuss
later
nonrespond
patient
issu
understand
mechan
underli
treatment
failur
determin
whether
altern
therapi
could
design
figur
genomewid
associ
studi
identifi
variou
singl
nucleotid
polymorph
snp
gene
encod
one
ifniii
well
noncod
region
one
snp
call
locat
kb
upstream
gene
patient
harbor
cc
genotyp
favor
prognosi
ifni
treatment
patient
tt
genotyp
high
risk
treatment
failur
european
favor
cc
genotyp
major
common
allel
unfavor
tt
snp
minor
allel
frequenc
allel
revers
african
favor
allel
allow
escap
mrna
degrad
cellular
microrna
induc
upon
hcv
infect
recent
genotyp
hepat
isg
express
consid
independ
predictor
respons
treatment
hcv
patient
propos
potenti
explan
integr
factor
rel
simpl
model
figur
main
hypothesi
effici
control
hcv
infect
depend
hepatocyt
respons
rather
support
report
induc
stronger
sustain
isg
express
hepatocyt
cell
line
vitro
polyi
cinduc
control
hcv
replic
human
liver
chimer
mice
correl
induct
ifni
human
hepatocyt
respond
patient
harbor
favor
allel
prevent
degrad
correspond
rna
infect
cell
might
express
signific
level
endogen
although
disput
howev
express
low
level
limit
effici
figur
patient
benefit
treatment
could
induc
express
hepatocyt
thu
boost
endogen
effect
contrast
high
isgexpress
nonrespond
patient
harbor
unfavor
allel
might
express
enough
viru
control
howev
express
result
endogen
product
ifni
henc
might
ineffect
patient
alreadi
express
fail
produc
endogen
due
degrad
mrna
infect
hepatocyt
figur
patient
may
good
candid
therapi
current
undergo
clinic
develop
sinc
express
mainli
restrict
epitheli
cell
melanocyt
hepatocyt
side
effect
relat
ifni
treatment
might
strongli
attenu
therapi
howev
ifni
key
induc
antivir
immun
respons
critic
determin
whether
besid
viral
clearanc
therapi
also
induc
longterm
immun
protect
hcv
ifni
transduc
intracellular
signal
singl
receptor
ifnar
via
multitud
downstream
signal
pathway
janu
activ
kinas
jak
stat
pathway
first
identifi
ifnar
compos
two
distinct
subunit
constitut
associ
member
jak
famili
tyrosin
kinas
respect
bind
ifni
receptor
lead
phosphoryl
turn
induc
phosphoryl
activ
stat
protein
differ
stat
complex
form
upon
trigger
ifnar
figur
transcript
complex
form
condit
ifni
stimul
induc
express
mani
molecul
cellintrins
antivir
immun
interferonstimul
gene
factor
heterotrim
compos
figur
follow
transloc
nucleu
bind
isr
regulatori
sequenc
target
gene
mani
molecul
play
key
role
function
innat
adapt
immun
leukocyt
also
induc
includ
dc
granzym
b
nk
cell
gener
compos
phosphoryl
phosphoryl
howev
altern
complex
describ
variou
context
could
particip
divers
ifni
effect
homodim
also
play
promin
role
cellintrins
ifnidepend
gene
induct
bind
sequenc
ga
control
express
mani
proinflammatori
molecul
homodim
form
upon
stimul
either
ifni
mani
gasregul
gene
induc
either
cytokin
depend
cell
type
jak
signal
downstream
ifnar
lead
activ
virtual
stat
protein
combinatori
associ
varieti
complex
differ
affin
specif
ga
element
figur
divers
contribut
ifni
induct
differ
transcript
program
distinct
cell
type
stat
complex
format
depend
part
rel
abund
stat
molecul
cell
activ
cell
popul
mainli
activ
lymphocyt
exampl
quiescent
nk
cell
express
lead
constitut
associ
ifnar
cell
henc
quiescent
nk
cell
mount
homodimerdepend
respons
ifni
stimul
includ
product
tbetdriven
prolifer
figur
chang
stat
level
also
occur
upon
differentiationactiv
given
cell
type
lead
shift
function
respons
cytokin
upon
activ
nk
cell
decreas
express
increas
shift
ifni
respons
quiescent
state
preactiv
cell
translat
opposit
ifni
effect
product
prolifer
quiescent
versu
preactiv
nk
cell
howev
outcom
modul
simultan
exposur
cytokin
revers
shift
occur
dc
matur
shift
function
respons
inhibit
activ
product
respons
combin
stimul
ifni
enabl
matur
dc
effici
activ
cell
yet
unknown
mechan
control
format
differ
stat
complex
distinct
cell
type
natur
dynam
signal
pathway
trigger
evalu
bulk
cultur
human
blood
leukocyt
use
flow
cytometri
high
throughput
mass
cytometri
divers
phosphoryl
pattern
observ
upon
ifni
stimul
activ
induc
phosphoryl
cell
type
peak
min
phosphoryl
found
poor
b
cell
compar
monocyt
cell
howev
underli
mechan
remain
identifi
sinc
b
cell
express
lower
amount
enhanc
level
inhibitori
molecul
high
activ
monocyt
led
induct
ifnidepend
proapoptot
gene
case
b
cell
result
strikingli
differ
obtain
studi
upon
stimul
phosphoryl
contrari
lower
monocyt
prolong
b
cell
nk
cell
differ
two
studi
might
result
use
differ
subset
dose
ifni
case
studi
consist
report
cell
show
highest
activ
cell
cell
activ
longer
time
activ
delay
cell
b
cell
compar
cell
monocyt
differ
stat
complex
may
lead
distinct
transcript
program
link
differ
biolog
function
figur
systemat
studi
need
understand
complex
besid
chang
stat
level
cell
type
activ
state
process
control
differenti
format
stat
complex
downstream
ifnar
trigger
remain
identifi
addit
jakstat
signal
pathway
activ
downstream
ifnar
includ
involv
phosphatidylinositol
mitogenactiv
protein
kinas
mapk
crk
adaptor
molecul
lead
activ
transcript
factor
irf
contribut
orchestr
cell
respons
cytokin
regul
distinct
overlap
set
gene
compar
stat
summari
ifnar
signal
remark
divers
pathway
includ
limit
divers
combin
kinet
stat
phosphoryl
explain
least
part
divers
ifni
effect
includ
induct
opposit
respons
depend
physiopatholog
context
andor
natur
princip
respond
cell
type
ifniii
induc
signal
pathway
ifni
although
engag
differ
heterodimer
receptor
compos
chain
preferenti
express
epitheli
cell
includ
hepatocyt
mice
human
be
numer
ifni
subtyp
exist
function
popul
genet
analys
show
ifni
subtyp
significantli
differ
function
henc
one
extraordinari
featur
ifni
biolog
ifni
subtyp
elicit
mani
pleiotrop
divers
function
interact
receptor
complex
requir
initi
ifnidepend
signal
mice
defici
either
one
highli
suscept
viral
infect
assembl
ifnreceptor
ternari
complex
twostep
process
first
binari
complex
form
bind
one
side
ifn
molecul
singl
binari
complex
interact
via
side
ifn
molecul
stabil
ternari
complex
determin
part
associ
dissoci
kinet
cytokin
two
receptor
chain
well
ifnar
express
level
sinc
cell
surfac
concentr
receptor
subunit
rel
low
henc
affin
ifni
subset
ifnar
amount
ifni
regul
biolog
effect
figur
cell
membran
densiti
also
involv
differenti
versu
function
activ
antiprolif
function
varieti
cellintrins
paramet
also
impact
lifetim
ifnreceptor
ternari
complex
rate
endocytosisdegradationrecycl
signal
complex
neg
isg
regul
decreas
affin
bind
base
definit
prototyp
cytokinereceptor
bind
modul
analog
epo
receptor
system
ifni
subtyp
origin
postul
form
ternari
complex
differ
architectur
result
distinct
geometri
assembl
intracellular
signal
compon
experiment
evid
reject
hypothesi
rather
differenti
activ
ifni
subtyp
determin
stabil
ligandreceptor
ternari
complex
differenti
affin
ifni
subtyp
extracellular
domain
gener
subtypespecif
signal
cascad
biolog
outcom
figur
crystal
structur
ternari
complex
illumin
biochem
complex
ifni
interact
cognat
receptor
main
conform
featur
ternari
complex
conserv
among
differ
ifni
quit
differ
cytokin
receptor
format
binari
complex
ifni
ligand
discrimin
resid
differenti
energet
interact
anchor
point
share
ifni
well
key
amino
acid
substitut
among
ifni
subtyp
perform
major
conform
chang
interact
ifni
associ
binari
complex
thu
display
optim
function
plastic
differ
chemistri
ifni
subtyp
interact
thu
explain
differ
affin
versu
within
ternari
complex
differenti
activ
function
regul
ifni
strongli
depend
main
respond
cell
type
figur
studi
vitro
examin
function
consequ
stimul
differ
cell
type
ifni
vivo
determin
contribut
cellintrins
ifni
respons
differ
cell
type
resist
suscept
variou
diseas
emerg
concept
central
role
dc
respons
ifni
induct
protect
immun
viral
infect
tumor
figur
develop
mutant
mice
allow
condit
genet
inactiv
celltyp
specif
manner
use
crelox
system
instrument
acceler
understand
differ
cell
type
respond
ifni
vivo
respect
contribut
protect
deleteri
ifni
respons
investig
extens
viral
infect
also
cancer
bacteri
infect
autoimmun
sepsi
inflammatori
diseas
effort
pursu
better
understand
cell
type
respond
ifni
manner
promot
protect
versu
deleteri
effect
differ
physiopatholog
set
knowledg
consider
help
develop
novel
strategi
modul
ifni
function
promot
health
diseas
develop
mutant
mice
allow
condit
genet
inactiv
help
better
understand
differ
signal
pathway
differ
cell
type
determin
outcom
ifni
respons
vivo
variou
condit
knowledg
might
lead
develop
strategi
aim
target
given
cell
type
specif
subset
ifni
presenc
antagonist
certain
signal
pathway
surgic
tune
ifni
respons
vivo
toward
desir
outcom
format
specif
stat
complex
highli
dynam
process
depend
cell
type
also
specif
state
time
see
ifni
henc
major
paramet
control
effect
ifni
given
cell
type
also
includ
microenviron
figur
time
exposur
cytokin
term
durat
stimul
previou
activ
histori
figur
tam
receptor
ligand
express
within
tumor
cell
variou
solid
cancer
elev
express
bad
prognosi
differ
cancer
mous
model
ovarian
cancer
earli
tumorigenesi
tumorinfiltr
dc
found
immunogen
promot
antitumor
immun
later
alter
cours
tumor
develop
acquir
immunosuppress
properti
benefici
tumor
one
may
thu
hypothes
express
tam
solubl
ligand
certain
tumor
tam
receptor
tumorinfiltr
dc
might
contribut
dampen
dc
respons
ifni
therefor
facilit
polar
tumor
microenviron
immunosuppress
cell
figur
acut
versu
chronic
exposur
ifni
lead
strikingli
opposit
effect
given
cell
type
addit
durat
time
cell
expos
ifni
also
dramat
impact
function
respons
depend
previou
activ
histori
figur
vitro
stimul
dc
lead
opposit
outcom
depend
whether
occur
simultan
matur
polar
dc
toward
induct
former
case
toward
cell
latter
case
opposit
effect
result
least
part
differenti
express
dc
similarli
ifni
effect
function
polar
cell
strongli
modul
cytokin
present
lymphocyt
microenviron
time
ifni
also
mediat
opposit
effect
cell
depend
whether
occur
cognat
engag
cell
receptor
inde
cell
potenti
respond
ifni
induc
gene
depend
upon
activ
histori
cell
respond
mostli
ifni
signal
lead
inhibit
prolifer
eventu
induct
apoptosi
howev
cognat
trigger
cell
receptor
caus
decreas
increas
express
cell
lead
shift
ifni
respons
signal
result
promot
prolifer
product
lcmv
infect
mechan
promot
expans
antivir
cell
inhibit
cell
prolifer
ifniinduc
side
effect
consequ
pleiotrop
natur
ifni
bioactiv
mediat
deleteri
effect
degre
independ
mediat
benefici
effect
one
could
mutat
ifni
molecul
order
skew
activ
toward
desir
bioactiv
inde
introduc
key
mutat
allow
increas
affin
factor
accordingli
mutant
potent
inhibit
cell
prolifer
potent
wt
induc
antivir
state
henc
possibl
tune
ifn
activ
modifi
bind
ifnar
howev
translat
approach
design
molecul
clinic
applic
sever
hamper
poor
understand
ifni
bioactiv
mediat
side
effect
furthermor
far
establish
list
bioactiv
could
differenti
modul
chang
stabil
ifniifnar
complex
know
cell
type
mediat
benefici
versu
deleteri
ifn
respons
variou
diseas
henc
discuss
strategi
aim
focus
ifn
activ
specif
cell
type
promot
health
diseas
sever
strategi
develop
specif
target
ifn
tumor
cell
tumorinfiltr
immun
cell
infect
tissu
strategi
includ
intralesion
inject
adenoviralmedi
gene
transfer
engin
tumorinfiltr
monocyt
fusion
ifn
cleavabl
protect
shell
anoth
strategi
increas
cytokin
accumul
within
tumor
infect
tissu
antibodymedi
target
cytokin
deliveri
cytokin
moieti
fuse
antibodi
direct
specif
cell
surfac
marker
figur
fusion
molecul
retain
antigenbind
ifni
bioactiv
enrich
target
site
upon
vivo
inject
target
human
ifni
inhibit
prolifer
lymphoma
cell
engraft
immunodefici
mice
ifni
target
tumor
antigen
also
amplifi
therapeut
effect
antibodi
act
tumorinfiltr
dc
thu
increas
antigen
crosspresent
antitumor
cytotox
cell
respons
nontarget
cell
antibodi
conjug
neg
impact
ifni
potenc
modestli
figur
fusion
molecul
gener
retain
full
ifni
biolog
activ
cell
express
antibodi
target
figur
henc
differ
lead
modest
ratio
ifni
specif
activ
measur
target
nontarget
cell
figur
target
effici
definit
low
reduc
toxic
effect
ifni
administr
specif
focu
ifni
activ
benefici
cell
without
stimul
deleteri
cell
engin
immunoifni
must
improv
reach
high
target
efficaci
requir
significantli
diminish
treatment
side
effect
recent
report
innov
strategi
reach
goal
base
postul
antibodi
moieti
immunoifni
stabil
ifnireceptorcomplex
avid
also
take
account
fact
biolog
potenc
ifni
proport
stabil
ifnireceptor
complex
certain
threshold
beyond
increas
stabil
increas
potenc
use
immunoifni
studi
evolv
retain
close
maxim
potenc
henc
target
antibodi
provid
modest
gain
term
biolog
potenc
howev
expect
decreas
affin
ifni
receptor
introduc
mutat
would
increas
target
effect
antibodi
figur
c
inde
case
use
ifni
singl
point
mutat
dramat
decreas
affin
figur
allow
engin
immunoifn
potent
cell
express
antibodi
target
figur
three
log
target
effici
novel
type
immunoifn
found
variou
activ
measur
vitro
vivo
deliv
mice
toxic
side
effect
experienc
patient
treat
ifni
due
system
ifni
activ
target
technolog
may
find
consider
clinic
applic
sinc
engin
immunoifn
virtual
inact
en
rout
activ
bind
fuse
antibodi
desir
target
remain
defin
use
target
accord
patholog
exampl
tumor
cell
profession
crosspres
dc
cancer
hepatocyt
chronic
hcv
infect
treat
autoimmun
diseas
novel
therapeut
target
ifni
develop
includ
two
monoclon
antibodi
current
clinic
trial
sifalimumab
rontalizumab
howev
longterm
system
neutral
ifni
activ
may
increas
suscept
viral
infect
tumor
develop
altern
strategi
need
specif
inhibit
ifni
deleteri
effect
diseas
without
global
compromis
ifni
antivir
antitumor
function
sequenti
natur
assembl
ifnireceptor
complex
open
possibl
design
ifni
antagonist
specif
target
cell
subset
respons
ifni
deleteri
effect
carri
singl
amino
acid
substitut
block
interact
engag
complex
bind
sinc
binari
complex
devoid
ifni
activ
mutant
behav
potent
ifni
antagonist
link
antibodi
specif
cell
surfac
marker
antagonist
activ
mutant
ifni
significantli
reinforc
specif
cell
express
target
henc
possibl
design
construct
target
antagonist
inhibit
respons
endogen
ifni
specif
cell
subset
cytokin
act
promot
autoimmun
sever
side
effect
leav
cell
fulli
respons
exampl
chronic
hcv
patient
treat
one
deleteri
side
effect
nervou
depress
might
prevent
coadministr
ifni
antagonist
specif
target
neuron
cell
central
nervou
system
last
decad
sever
major
technolog
breakthrough
gener
novel
anim
model
remark
advanc
understand
mode
action
ifn
vitro
high
throughput
screen
allow
systemat
studi
function
isg
ectop
express
knockdown
advanc
biophys
investig
interact
ifni
ifni
receptor
allow
rigor
investig
mechanist
basi
differenti
bioactiv
ifni
subtyp
analys
respons
differ
cell
type
ifn
viral
infect
vitro
also
vivo
variou
patholog
demonstr
ifni
often
mediat
benefici
versu
deleteri
role
act
differ
cell
type
integr
analysi
data
pictur
emerg
suggest
possibl
segreg
protect
deleteri
ifni
effect
base
differenti
induct
depend
ifni
subset
magnitudetim
ifni
product
ii
condit
differ
tissu
iii
occurr
differ
cell
type
henc
innov
immunotherapeut
treatment
design
tune
ifni
activ
toward
desir
effect
order
promot
health
diseas
manner
adapt
physiopatholog
condit
particular
proofofconcept
made
vitro
possibl
target
ifni
activ
given
cell
type
tissu
administ
patient
suffici
high
dose
cytokin
site
interest
limit
unwant
effect
tissu
cell
type
next
step
demonstr
efficaci
strategi
vivo
preclin
anim
model
importantli
foster
develop
innov
immunotherapi
major
effort
still
warrant
continu
delin
cell
type
mainli
respons
protect
versu
deleteri
effect
ifni
differ
diseas
combin
high
throughput
technolog
system
biolog
approach
also
advanc
understand
molecular
mechan
dynam
control
ifni
respons
health
diseas
reveal
potenti
novel
therapeut
target
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
